Search Results - Helga Gardarsdottir

Type and Extent of Information on (Potentially Critical) Quality Attributes Described in European Public Assessment Reports for Adalimumab Biosimilars by Ali M. Alsamil, Thijs J. Giezen, Toine C. Egberts, Hubert G. Leufkens, Helga Gardarsdottir

Connect to this object online.

Companies' Health Technology Assessment Strategies and Practices in Australia, Canada, England, France, Germany, Italy and Spain: An Industry Metrics Study by Ting Wang, Ting Wang, Neil McAuslane, Lawrence Liberti, Helga Gardarsdottir, Wim Goettsch, Wim Goettsch, Hubert Leufkens

Connect to this object online.

Pharmacists' Activities to Reduce Medication Waste: An International Survey by Charlotte L. Bekker, Helga Gardarsdottir, Antoine C. G. Egberts, Marcel L. Bouvy, Bart J. F. van den Bemt

Connect to this object online.

Implementation and performance of haemovigilance systems in 10 sub-saharan African countries is sub-optimal by Washington T. Samukange, Verena Kluempers, Manvi Porwal, Linda Mudyiwenyama, Khamusi Mutoti, Noel Aineplan, Helga Gardarsdottir, Aukje K. Mantel-Teeuwisse, C. Micha Nuebling

Connect to this object online.

What does it cost to redispense unused medications in the pharmacy? A micro-costing study by Charlotte L. Bekker, Helga Gardarsdottir, Antoine C. G. Egberts, Hendrik A. Molenaar, Marcel L. Bouvy, Bart J. F. van den Bemt, Anke M. Hövels

Connect to this object online.

Switching TNFα inhibitors: Patterns and determinants by Rosanne W. Meijboom, Helga Gardarsdottir, Matthijs L. Becker, Mark C. H. de Groot, Kris L. L. Movig, Johan Kuijvenhoven, Toine C. G. Egberts, Hubert G. M. Leufkens, Thijs J. Giezen

Connect to this object online.